Home/Filings/4/0000905148-25-001092
4//SEC Filing

Ahmad Qasim Iftikhar 4

Accession 0000905148-25-001092

CIK 0001865494other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:09 PM ET

Size

5.3 KB

Accession

0000905148-25-001092

Insider Transaction Report

Form 4
Period: 2025-04-02
Ahmad Qasim Iftikhar
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-04-02+215,000215,000 total
    Exercise: $1.07Exp: 2035-04-02Common Stock (215,000 underlying)
Footnotes (1)
  • [F1]One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.

Documents

1 file

Issuer

IO Biotech, Inc.

CIK 0001865494

Entity typeother

Related Parties

1
  • filerCIK 0001985801

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:09 PM ET
Size
5.3 KB